Osteoporosis in patients with systemic lupus erythematosus. 2009

Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
Systemic Autoinmune Diseases Research Unit, Hospital General Regional No. 36, IMSS, Puebla, Mexico.

In recent years the survival of patients with systemic lupus erythematosus has increased markedly. Consequently, long-term complications, such as osteoporosis, are currently of paramount importance. SLE is known to increase the risk of bone fractures, and numerous studies have found that SLE patients have osteoporosis. Of the various risk factors associated with osteoporosis in SLE, disease duration, the use of corticosteroids and chronic disease-related damage are consistently reported, with differences between studies probably due to the different populations studied. The role of chronic inflammation in osteoporosis is also important. On the other hand, little attention has been paid to osteoporotic fractures, especially of the vertebra, which are associated with reduced quality of life, increased mortality rates and increased risk of new vertebral and non-vertebral fractures in the general population.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
May 2005, Rheumatic diseases clinics of North America,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
January 2004, Lupus,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
October 2014, The Journal of rheumatology,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
January 2012, Arthritis care & research,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
May 2000, Rheumatic diseases clinics of North America,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
December 2023, Modern rheumatology,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
December 2015, Current opinion in endocrinology, diabetes, and obesity,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
January 2001, Lupus,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
January 2016, Lupus science & medicine,
Mario García-Carrasco, and Claudia Mendoza-Pinto, and Ricardo O Escárcega, and Mario Jiménez-Hernández, and Ivet Etchegaray Morales, and Pamela Munguía Realpozo, and Jaime Rebollo-Vázquez, and Elena Soto-Vega, and Margarita Delezé, and Ricard Cervera
February 1996, Ryumachi. [Rheumatism],
Copied contents to your clipboard!